Stock listing
KRX:321550 TiumBio Co., Ltd. (티움바이오) 주가
Follow TiumBio Co., Ltd. into a list and get an email when it puts out news.
Share price · KRX:321550
₩3,440.00 KRW +45.00 (+1.3%)
Close on Nov 20, 2026
- Day range
- ₩3,300.00 – ₩3,665.00 KRWNov 20, 2026
- Volume
- 66,017 sharesNov 20, 2026
- Market cap
- ₩103.3B KRWAt the close on Nov 20, 2026 · price × 30.04M shares outstanding
- 52-week range
- ₩3,240.00 – ₩13,700.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩481.2M KRWMedian day 86,581 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:321550 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩3,440.00 | +45.00 | +1.3% | ₩3,505.00 | ₩3,665.00 | ₩3,300.00 | 66,017 | |
| ₩3,395.00 | +50.00 | +1.5% | ₩3,435.00 | ₩3,440.00 | ₩3,280.00 | 51,559 | |
| ₩3,345.00 | -35.00 | -1.0% | ₩3,400.00 | ₩3,440.00 | ₩3,280.00 | 63,018 | |
| ₩3,380.00 | -85.00 | -2.5% | ₩3,465.00 | ₩3,500.00 | ₩3,320.00 | 90,973 | |
| ₩3,465.00 | -220.00 | -6.0% | ₩3,690.00 | ₩3,870.00 | ₩3,465.00 | 104,102 | |
| ₩3,685.00 | -30.00 | -0.8% | ₩3,615.00 | ₩3,900.00 | ₩3,615.00 | 99,973 | |
| ₩3,715.00 | +110.00 | +3.1% | ₩3,725.00 | ₩3,800.00 | ₩3,555.00 | 76,671 | |
| ₩3,605.00 | +125.00 | +3.6% | ₩3,480.00 | ₩3,730.00 | ₩3,480.00 | 54,752 | |
| ₩3,480.00 | -20.00 | -0.6% | ₩3,240.00 | ₩3,640.00 | ₩3,240.00 | 95,903 | |
| ₩3,500.00 | -90.00 | -2.5% | ₩3,380.00 | ₩3,640.00 | ₩3,375.00 | 117,748 | |
| ₩3,590.00 | -55.00 | -1.5% | ₩3,660.00 | ₩3,835.00 | ₩3,585.00 | 90,188 | |
| ₩3,645.00 | -10.00 | -0.3% | ₩3,640.00 | ₩4,000.00 | ₩3,400.00 | 367,935 | |
| ₩3,655.00 | +115.00 | +3.2% | ₩3,475.00 | ₩3,775.00 | ₩3,475.00 | 85,321 | |
| ₩3,540.00 | -95.00 | -2.6% | ₩3,625.00 | ₩3,630.00 | ₩3,375.00 | 175,746 | |
| ₩3,635.00 | -80.00 | -2.2% | ₩3,825.00 | ₩3,825.00 | ₩3,400.00 | 238,411 | |
| ₩3,715.00 | -120.00 | -3.1% | ₩3,780.00 | ₩3,885.00 | ₩3,640.00 | 89,148 | |
| ₩3,835.00 | -70.00 | -1.8% | ₩3,905.00 | ₩4,175.00 | ₩3,720.00 | 185,311 | |
| ₩3,905.00 | -140.00 | -3.5% | ₩4,040.00 | ₩4,165.00 | ₩3,860.00 | 126,209 | |
| ₩4,045.00 | -35.00 | -0.9% | ₩4,075.00 | ₩4,190.00 | ₩3,975.00 | 47,743 | |
| ₩4,080.00 | 0.00 | 0.0% | ₩4,105.00 | ₩4,110.00 | ₩3,965.00 | 62,570 | |
| ₩4,080.00 | -135.00 | -3.2% | ₩4,165.00 | ₩4,265.00 | ₩4,030.00 | 64,146 | |
| ₩4,215.00 | +70.00 | +1.7% | ₩4,145.00 | ₩4,290.00 | ₩4,050.00 | 37,322 | |
| ₩4,145.00 | -105.00 | -2.5% | ₩4,230.00 | ₩4,295.00 | ₩4,065.00 | 51,704 | |
| ₩4,250.00 | +190.00 | +4.7% | ₩4,000.00 | ₩4,330.00 | ₩3,980.00 | 37,385 | |
| ₩4,060.00 | +125.00 | +3.2% | ₩3,935.00 | ₩4,155.00 | ₩3,935.00 | 37,796 | |
| ₩3,935.00 | -220.00 | -5.3% | ₩3,985.00 | ₩4,060.00 | ₩3,860.00 | 109,764 | |
| ₩4,155.00 | +75.00 | +1.8% | ₩4,000.00 | ₩4,225.00 | ₩4,000.00 | 52,238 | |
| ₩4,080.00 | -140.00 | -3.3% | ₩4,115.00 | ₩4,195.00 | ₩3,870.00 | 171,216 | |
| ₩4,220.00 | -320.00 | -7.0% | ₩4,600.00 | ₩4,600.00 | ₩4,155.00 | 124,809 | |
| ₩4,540.00 | -185.00 | -3.9% | ₩4,830.00 | ₩4,830.00 | ₩4,400.00 | 109,369 | |
| ₩4,725.00 | 0.00 | 0.0% | ₩4,655.00 | ₩4,865.00 | ₩4,655.00 | 97,026 | |
| ₩4,725.00 | +200.00 | +4.4% | ₩4,550.00 | ₩4,735.00 | ₩4,520.00 | 110,948 | |
| ₩4,525.00 | -370.00 | -7.6% | ₩4,935.00 | ₩4,940.00 | ₩4,485.00 | 231,683 | |
| ₩4,895.00 | +415.00 | +9.3% | ₩4,495.00 | ₩4,895.00 | ₩4,495.00 | 148,938 | |
| ₩4,480.00 | 0.00 | 0.0% | ₩4,500.00 | ₩4,555.00 | ₩4,440.00 | 28,672 | |
| ₩4,480.00 | -20.00 | -0.4% | ₩4,520.00 | ₩4,520.00 | ₩4,415.00 | 51,134 | |
| ₩4,500.00 | +60.00 | +1.4% | ₩4,450.00 | ₩4,665.00 | ₩4,440.00 | 109,690 | |
| ₩4,440.00 | -35.00 | -0.8% | ₩4,550.00 | ₩4,575.00 | ₩4,345.00 | 117,810 | |
| ₩4,475.00 | -190.00 | -4.1% | ₩4,620.00 | ₩4,695.00 | ₩4,470.00 | 49,293 | |
| ₩4,665.00 | +185.00 | +4.1% | ₩4,480.00 | ₩4,720.00 | ₩4,300.00 | 118,305 | |
| ₩4,480.00 | -115.00 | -2.5% | ₩4,560.00 | ₩4,635.00 | ₩4,440.00 | 63,137 | |
| ₩4,595.00 | +85.00 | +1.9% | ₩4,490.00 | ₩4,595.00 | ₩4,450.00 | 27,582 | |
| ₩4,510.00 | -60.00 | -1.3% | ₩4,625.00 | ₩4,835.00 | ₩4,400.00 | 78,763 | |
| ₩4,570.00 | +90.00 | +2.0% | ₩4,340.00 | ₩4,665.00 | ₩4,340.00 | 60,667 | |
| ₩4,480.00 | -175.00 | -3.8% | ₩4,660.00 | ₩4,770.00 | ₩4,480.00 | 65,383 | |
| ₩4,655.00 | -10.00 | -0.2% | ₩4,650.00 | ₩4,695.00 | ₩4,565.00 | 43,039 | |
| ₩4,665.00 | -125.00 | -2.6% | ₩4,785.00 | ₩4,785.00 | ₩4,510.00 | 100,708 | |
| ₩4,790.00 | +230.00 | +5.0% | ₩4,560.00 | ₩4,790.00 | ₩4,360.00 | 137,500 | |
| ₩4,560.00 | -165.00 | -3.5% | ₩4,730.00 | ₩4,740.00 | ₩4,520.00 | 203,224 | |
| ₩4,725.00 | +355.00 | +8.1% | ₩4,565.00 | ₩5,680.00 | ₩4,565.00 | 1,186,691 | |
| ₩4,370.00 | +15.00 | +0.3% | ₩4,380.00 | ₩4,415.00 | ₩4,275.00 | 52,795 | |
| ₩4,355.00 | +15.00 | +0.3% | ₩4,345.00 | ₩4,385.00 | ₩4,245.00 | 65,536 | |
| ₩4,340.00 | -50.00 | -1.1% | ₩4,260.00 | ₩4,435.00 | ₩4,210.00 | 55,920 | |
| ₩4,390.00 | +140.00 | +3.3% | ₩4,250.00 | ₩4,390.00 | ₩4,180.00 | 56,186 | |
| ₩4,250.00 | -35.00 | -0.8% | ₩4,285.00 | ₩4,290.00 | ₩4,100.00 | 78,439 | |
| ₩4,285.00 | +45.00 | +1.1% | ₩4,295.00 | ₩4,300.00 | ₩4,180.00 | 42,048 | |
| ₩4,240.00 | +120.00 | +2.9% | ₩4,040.00 | ₩4,275.00 | ₩4,040.00 | 93,894 | |
| ₩4,120.00 | -5.00 | -0.1% | ₩4,095.00 | ₩4,205.00 | ₩4,045.00 | 49,718 | |
| ₩4,125.00 | +25.00 | +0.6% | ₩4,100.00 | ₩4,180.00 | ₩3,900.00 | 137,845 | |
| ₩4,100.00 | -50.00 | -1.2% | ₩4,175.00 | ₩4,275.00 | ₩4,035.00 | 87,841 | |
| ₩4,150.00 | -230.00 | -5.3% | ₩4,415.00 | ₩4,415.00 | ₩3,890.00 | 168,829 | |
| ₩4,380.00 | +50.00 | +1.2% | ₩4,545.00 | ₩4,585.00 | ₩4,325.00 | 77,009 |
- Ticker
- KRX:321550
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
What changed lately
Latest news
TiumBio Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 1 in the last 12 months · 3 in all · newest May 31, 2026 · oldest 2025
- Decks
- 1 deck · latest Jan 26, 2024
Valuation
EV/sales 5.4× against a median of 48.1×: 3rd lowest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩81.03B KRW
- P/E
- Loss
- EV/sales
- 5.4×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 2.9×
- Gross margin
- 39.5%
- Operating margin
- −107.2%
- Net margin
- −114.1%
- Debt to equity
- 0.3×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| TiumBio Co., Ltd. · KRX:321550 | US$76.77M | US$60.20M | n/a | 5.4× | n/a | 2.9× | −114.1% | 0.3× | n/a |
| Vaxart, Inc. · OTC:VXRT | US$79.89M | US$14.34M | 2.8× | 0.1× | 0.4× | 1.2× | 16.0% | 0.0× | 1.21 |
| Sensorion SAS · EURONEXT:ALSEN | US$79.63M | −US$13.98M | n/a | n/a | n/a | 0.9× | n/a | 0.0× | n/a |
| Adocia SA · EURONEXT:ADOC | US$79.30M | US$77.84M | n/a | 48.1× | n/a | n/a | n/a | n/a | n/a |
| Tiziana Life Sciences Ltd · NASDAQ:TLSA | US$78.98M | US$76.73M | n/a | n/a | n/a | n/a | n/a | n/a | 1.23 |
| Nyrada, Inc. · ASX:NYR | US$78.76M | US$73.21M | n/a | n/a | n/a | 12.5× | n/a | 0.0× | n/a |
| HLB Therapeutics Co., Ltd. · KRX:115450 | US$76.35M | US$66.52M | n/a | 1.4× | n/a | 0.7× | −28.0% | 0.0× | n/a |
| Recce Pharmaceuticals Ltd. · ASX:RCE | US$75.90M | US$81.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Black Diamond Therapeutics, Inc. · NASDAQ:BDTX | US$75.28M | −US$10.71M | n/a | n/a | n/a | 0.8× | n/a | 0.2× | 1.76 |
| Great Novel Therapeutics Biotech & Medicals Corp. · TPEX:7427 | US$73.92M | US$52.72M | n/a | 1,442× | n/a | 3.2× | n/a | 0.0× | n/a |
| Pentixapharm Holding AG · XETR:PTP | US$73.87M | US$69.92M | n/a | 1,158× | n/a | 2.4× | n/a | 0.0× | n/a |
| Median of the others | US$77.56M | US$68.22M | 2.8× | 48.1× | 0.4× | 1.2× | −6.0% | 0.0× | 1.23 |
Team and board
| Officer | Role |
|---|---|
| Da-ye Song | Manager, Corporate Communications & Investor Relations |
| Dong-ho Kang | Head of Corporate Communications & Investor Relations |
| Hyun-kyoung Kim | Manager, Corporate Communications & Investor Relations |
| Junseok Jang | Head of Corporate Communications & Investor Relations |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2024) | Investor deck | 29 slides | Jan 26, 2024 |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.3B | 6.79B | 4.90B | 9.12B | 56.8M | 1.05B | 1.11B | 1.13B | 225.5M |
| Cost of revenue | 7.24B | 4.84B | |||||||
| Gross profit | 5.04B | 6.79B | 4.90B | 9.12B | 56.8M | 1.05B | |||
| Research and development | 9.67B | 9.48B | 17.9B | 21.3B | 25.8B | 9.83B | |||
| Selling, general and administrative | 2.32B | 6.67B | 7.30B | 7.31B | 4.49B | 3.28B | 2.12B | 1.68B | 1.03B |
| Operating income | -16.1B | -5.34B | -16.0B | -25.0B | -32.7B | -13.3B | -8.02B | -5.24B | -4.24B |
| Depreciation and amortization | 3.68B | 3.45B | 2.72B | 3.47B | 1.94B | 1.02B | 834.3M | 142.2M | 84.0M |
| EBITDA | -12.5B | -1.89B | -13.3B | -21.5B | -30.8B | -12.3B | -7.19B | -5.10B | -4.16B |
| Interest expense | 5.45B | 4.04B | 2.47B | 808.4M | 518.5M | 40.8M | 0 | 0 | 0 |
| Income before tax | -18.8B | -23.5B | -19.0B | -31.4B | -32.3B | -12.1B | -7.09B | -13.8B | -8.79B |
| Net income | -17.4B | -20.6B | -17.9B | -29.9B | -31.6B | -12.1B | -7.09B | -13.8B | -8.79B |
| Earnings per share, basic | -590.44 | -772.82 | -727.42 | -1,242.92 | -1,322.78 | -509.54 | -302.28 | -593.00 | -379.25 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 10.8B | 788.0K | 10.5B | 609.0K | 365.0K | 3.46B | 16.9B | 1.86B | 2.27B |
| Short-term investments | 31.6B | 31.2B | 29.9B | -140 | 33.8B | 65.1B | 72.0B | 22.5B | 4.00B |
| Receivables | 1.60B | 1.76B | 537.4M | 90.8M | 23.4M | 544.0M | 608.1M | 1.35B | 16.3M |
| Inventory | 324.3M | 356.1M | |||||||
| Current assets | 50.9B | 58.9B | 45.3B | 40.3B | 41.9B | 69.9B | 90.4B | 25.9B | 6.55B |
| Property, plant and equipment | 44.7B | 42.0B | 24.4B | 14.8B | 2.68B | 859.4M | 432.6M | 483.6M | |
| Goodwill | 1.33B | 1.33B | |||||||
| Total assets | 98.6B | 107.3B | 119.5B | 96.3B | 116.7B | 85.4B | 93.5B | 29.3B | 10.1B |
| Accounts payable | 129.8M | 68.7M | |||||||
| Current liabilities | 46.0B | 39.3B | 11.7B | 30.1B | 4.47B | 1.78B | 958.3M | 574.8M | 400.4M |
| Long-term debt | 13.4B | 16.4B | 22.7B | 2.71B | 17.8B | ||||
| Total debt | 931.2M | ||||||||
| Total liabilities | 60.8B | 54.8B | 49.2B | 35.2B | 29.2B | 2.84B | 958.3M | 574.8M | 17.2B |
| Shareholders' equity | 40.8B | 52.5B | 70.1B | 61.0B | 87.6B | 82.5B | 92.5B | 28.7B | -7.09B |
| Shares outstanding | 29.4M | 26.7M | 24.6M | 24.0M | 23.9M | 23.8M | 23.5M | 23.2M | 23.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -15.3B | -15.6B | -20.6B | -16.0B | -24.8B | -9.38B | -4.45B | -5.05B | -3.61B |
| Capital spending | -382.2M | -1.04B | -18.4B | -11.2B | -11.8B | -867.2M | -503.4M | -236.7M | -3.46B |
| Free cash flow | -15.7B | -16.7B | -39.0B | -27.3B | -36.7B | -10.3B | -4.95B | -5.29B | -7.07B |
| Cash from investing | 24.7B | -9.63B | 24.4B | -24.8B | 9.57B | -64.2B | -18.9B | -7.77B | |
| Cash from financing | -2.75B | 23.0B | 2.78B | 53.0B | 598.1M | 69.6B | 23.5B | 13.7B | |
| Share buybacks | 11.1M | 12.3B | 711.5M | 25.6B | 856.9M | 71.5B | 1.65B | ||
| Change in cash | -5.69B | 5.95B | -7.62B | 11.2B | 3.42B | 580.0M | 1.02B | -413.6M | 2.27B |
Cap table
Built by 6ix from TiumBio Co., Ltd.’s releases
- Common shares
- 30,038,475
- Fully diluted
- 30,038,475
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 30,038,475 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 30,038,475 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Da-ye Song | Manager, Corporate Communications & Investor Relations · Since at least May 31, 2026 |
| Dong-ho Kang | Head of Corporate Communications & Investor Relations · Since at least May 31, 2026 |
| Hyun-kyoung Kim | Manager, Corporate Communications & Investor Relations · Since at least May 31, 2026 |
| Junseok Jang | Head of Corporate Communications & Investor Relations · Since at least May 7, 2025 |
Log in to ask 6ix AI your own questions about TiumBio Co., Ltd.